Restricted accessBrief reportFirst published online 2020-07-21
Becoming or Remaining Agitated: The Course of Agitation in People with Dementia Living in Care Homes. The English Longitudinal Managing Agitation and Raising Quality of Life (MARQUE) Study
Care home residents with dementia often have accompanying agitation. We investigated agitation’s course at 5 time-points in 1,424 people with dementia over 16 months in 86 English care homes. We categorized baseline agitation symptoms on the Cohen-Mansfield Agitation Inventory (CMAI) into none (CMAI = 29; 15%), subclinical (CMAI = 30–45; 45%), or clinically-significant (CMAI > 45; 40%). 88% of those with no agitation at baseline remained free of clinically-significant agitation at all follow-ups. Seventy percent of those exhibiting clinically-significant agitation at baseline had clinically-significant agitation at some follow-ups. Over a 16-month observation period, this study finds many care home residents with dementia never develop clinically significant agitation and interventions should be for treatment not prevention.
HoeJ, JesnickL, TurnerR, LeaveyG, LivingstonG (2017) Caring for relatives with agitation at home: A qualitative study of positive coping strategies. BJPsych Open3, 34–40.
2.
LivingstonG, BarberJ, MarstonL, RapaportP, LivingstonD, CousinsS, RobertsonS, La FrenaisF, CooperC (2017) Prevalence of and associations with agitation in residents with dementia living in care homes: MARQUE cross-sectional study. BJPsych Open3, 171–178.
3.
AnatchkovaM, BrooksA, SwettL, HartryA, DuffyRA, BakerRA, Hammer-HelmichL, Sanon AigbogunM (2019) Agitation in patients with dementia: A systematic review of epidemiology and association with severity and course. Int Psychogeriatrics. doi: 10.1017/S1041610218001898.
4.
PancaM, LivingstonG, BarberJ, CooperC, FrenaisF La, MarstonL, CousinsS, HunterRM (2019) Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study. PLoS One14, 1–11.
5.
HendriksSA, SmalbruggeM, Galindo-GarreF, HertoghCMPM, van der SteenJT (2015) From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia. J Am Med Dir Assoc16, 475–481.
6.
SelbækG, EngedalK, BenthJŠ, BerghS (2014) The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatrics26, 81–91.
7.
Cohen-MansfieldJ, BilligN (1986) Agitated behaviors in the elderly: I. A conceptual review. J Am Geriatr Soc34, 711–721.
8.
RyuSH, KatonaC, RiveB, LivingstonG (2005) Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: The LASER-AD study. Am J Geriatr Psychiatry13, 976–983.
9.
LevinE (1989) Noticeable Problems Checklist, National Institute for Social Work, London.
10.
SteventonA, RobertsA (2012) Estimating length of stay in publicly-funded residential and nursing care homes: A retrospective analysis using linked administrative data sets. BMC Health Serv Res12, 377.
11.
HughesCP, BergL, DanzigerWL, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
12.
LaybourneA, LivingstonG, CousinsS, RapaportP, LambeK, La FrenaisF, SavageH, ManelaM, StringerA, MarstonL, BarberJ, CooperC (2019) Carer coping and resident agitation as predictors of quality of life in care home residents living with dementia: Managing Agitation and Raising Quality of Life (MARQUE) English national care home prospective cohort study. Int J Geriatr Psychiatry34, 106–113.
13.
CooperC, LodwickR, WaltersK, RaineR, ManthorpeJ, IliffeS, PetersenI (2017) Inequalities in receipt of mental and physical healthcare in people with dementia in the UK. Age Ageing46, 393–400.
14.
LivingstonG, BarberJ, MarstonL, StringerA, PancaM, HunterR, CooperC, LaybourneA, La FrenaisF, ReevesS, ManelaM, LambeK, BanerjeeS, RapaportP (2019) Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial. Lancet Psychiatry6, 293–304.
15.
BallardC, CorbettA, OrrellM, WilliamsG, Moniz-CookE, RomeoR, WoodsB, GarrodL, TestadI, Woodward-CarltonB, WenbornJ, KnappM, FosseyJ (2018) Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial. PLoS Med15, e1002500.
16.
LichtwarckB, SelbaekG, KirkevoldØ, RokstadAMM, BenthJŠ, LindstrømJC, BerghS (2018) Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: a cluster randomized controlled trial. Am J Geriatr Psychiatry26, 25–38.
17.
CostelloH, WalshS, CooperC, LivingstonG (2019) A systematic review and meta-analysis of the prevalence and associations of stress and burnout among staff in long-term care facilities for people with dementia. Int Psychogeriatrics31, 1203–1216.
18.
RapaportP, LivingstonG, HamiltonO, TurnerR, StringerA, RobertsonS, CooperC (2018) How do care home staff understand, manage and respond to agitation in people with dementia? A qualitative study. BMJ Open8, e022260.
